MINNEAPOLIS, Minn. and ATHLONE, Ireland (April 13, 2016) – The Dow Chemical Company announced its investment in OxyMem Ltd.
The investment will accelerate the commercialization of OxyMem’s promising wastewater treatment technology, the Membrane Aerated Biofilm Reactor (MABR). The MABR technology has the potential to bring wastewater treatment closer to energy neutrality by reducing energy consumption for aeration by up to 75 percent.